Correlation Between Hookipa Pharma and Coherus BioSciences
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Coherus BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Coherus BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Coherus BioSciences, you can compare the effects of market volatilities on Hookipa Pharma and Coherus BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Coherus BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Coherus BioSciences.
Diversification Opportunities for Hookipa Pharma and Coherus BioSciences
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Hookipa and Coherus is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Coherus BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coherus BioSciences and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Coherus BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coherus BioSciences has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Coherus BioSciences go up and down completely randomly.
Pair Corralation between Hookipa Pharma and Coherus BioSciences
Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Coherus BioSciences. But the stock apears to be less risky and, when comparing its historical volatility, Hookipa Pharma is 1.93 times less risky than Coherus BioSciences. The stock trades about -0.49 of its potential returns per unit of risk. The Coherus BioSciences is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest 72.00 in Coherus BioSciences on August 28, 2024 and sell it today you would earn a total of 49.00 from holding Coherus BioSciences or generate 68.06% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Hookipa Pharma vs. Coherus BioSciences
Performance |
Timeline |
Hookipa Pharma |
Coherus BioSciences |
Hookipa Pharma and Coherus BioSciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hookipa Pharma and Coherus BioSciences
The main advantage of trading using opposite Hookipa Pharma and Coherus BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Coherus BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coherus BioSciences will offset losses from the drop in Coherus BioSciences' long position.Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
Coherus BioSciences vs. Assembly Biosciences | Coherus BioSciences vs. Spero Therapeutics | Coherus BioSciences vs. Achilles Therapeutics PLC | Coherus BioSciences vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |